Quick Answer
Incannex Healthcare Inc. reported Diluted EPS of $1.35 per share (loss) for fiscal year 2025.
Incannex Healthcare Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.35 | -17.4% |
| 2024 | -$1.15 | +65.4% |
| 2023 | -$3.32 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$0.02 | +93.9% | +0.0% |
| September 30, 2025 | -$0.02 | +93.1% | +90.0% |
| March 31, 2025 | -$0.20 | +47.4% | +39.4% |
| December 31, 2024 | -$0.33 | +0.0% | -13.8% |
| September 30, 2024 | -$0.29 | -262.5% | +23.7% |
| March 31, 2024 | -$0.38 | -72.7% | -15.2% |
| December 31, 2023 | -$0.33 | -760.0% | -312.5% |
| September 30, 2023 | -$0.08 | — | +63.6% |
- Incannex Healthcare Inc. showed a decrease of -17.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, Incannex Healthcare Inc.’s diluted eps has grown by 59.3% (from $3.32 per share (loss) to $1.35 per share (loss)).
- The most recent figure is from Incannex Healthcare Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: